Aim. EMBRACETMis an innovative, low cost infant warmer for use in neonates. It contains phase change material, which stays at constant temperature for 6 hours. We surveyed paediatricians using EMBRACETMregarding benefits, risks, and setup in which it was used in Gujarat.Methods. Questionnaire was administered telephonically to 52 out of 53 paediatricians.Results. EMBRACETMwas used for an average of 8.27 (range of 3–18, SD = 3.84) months by paediatricians. All used it for thermoregulation during transfers, for average (SD) duration of 42 (0.64) m per transfer, 62.7% used it at mother’s side for average (SD) 11.06 (7.89) h per day, and 3.9% prescribed it at home. It was used in low birth weight neonates only by 56.9% while 43.1% used it for all neonates. While hyperthermia was not reported, 5.9% felt that EMBRACETMdid not prevent hypothermia. About 54.9% felt that they could not monitor the newborn during EMBRACETMuse. Of paediatricians who practiced kangaroo mother care (KMC), 7.7% have limited/stopped/decreased the practice of KMC and substituted it with EMBRACETM.Conclusions. EMBRACETMwas acceptable to most but concerns related to monitoring neonates and disinfection remained. Most paediatricians felt that it did not hamper KMC practice.
Development of a Low-Cost and Vibration-Free Constant-Temperature Chamber for Precision Measurement
